Analysed Palvella Therapeutics Inc (PVLA:NASDAQ) News Sources
Palvella Therapeutics Announces Positive Topline Results from Phase 3 SELVA Clinical Study of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic ...
Yahoo Finance
Palvella Therapeutics to Host Conference Call to Discuss Topline Results from Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in ...
The Manila Times
What is the current price of Palvella Therapeutics Inc (PVLA:NASDAQ)?
The current price of Palvella Therapeutics Inc (PVLA:NASDAQ) is $128.6.
Palvella Therapeutics Inc (PVLA:NASDAQ) absolute price change since previous trading day?
The absolute price change of Palvella Therapeutics Inc (PVLA:NASDAQ) since the previous trading day is $8.19.
Palvella Therapeutics Inc (PVLA:NASDAQ) percentage price change since previous trading day?
The percentage price change of Palvella Therapeutics Inc (PVLA:NASDAQ) since the previous trading day is 6.80%.
What is This Week's average sentiment score for Palvella Therapeutics Inc (PVLA:NASDAQ)?
This Week's average sentiment score for Palvella Therapeutics Inc (PVLA:NASDAQ) is 73 out of 100.
What is This Week's average sentiment for Palvella Therapeutics Inc (PVLA:NASDAQ)?
This Week's sentiment for Palvella Therapeutics Inc (PVLA:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.